Efficacy of an educational intervention in primary health care in inhalation techniques: study protocol for a pragmatic cluster randomised controlled trial

José Leiva-Fernández, Rubén L Vázquez-Alarcón, Virginia Aguiar-Leiva, Mireya Lobnig-Becerra, Francisca Leiva-Fernández, Pilar Barnestein-Fonseca, José Leiva-Fernández, Rubén L Vázquez-Alarcón, Virginia Aguiar-Leiva, Mireya Lobnig-Becerra, Francisca Leiva-Fernández, Pilar Barnestein-Fonseca

Abstract

Background: Chronic obstructive pulmonary disease (COPD) accounts for 10-12 % of primary care consultations, 7 % of hospital admissions and 35 % of chronic incapacity related to productivity. The misuse of inhalers is a significant problem in COPD because it is associated with reduced therapeutic drug effects leading to lack of control of both symptoms and disease. Despite all advice, health care professionals' practice management of inhalation treatments is usually deficient. Interventions to improve inhaler technique by health care professionals are limited, especially among primary care professionals, who provide the most care to patients with COPD. The aim of this study is to evaluate the efficacy of an educational intervention to train general practitioners (GPs) in the right inhalation technique for the most commonly used inhalers.

Methods/design: We are conducting a pragmatic cluster randomised controlled trial. The sample population is composed of 267 patients diagnosed with COPD using inhalation therapy selected from among those in 20 general practices, divided into two groups (control and intervention) by block randomisation at 8 primary care centres. The sample has two levels. The first level is patients with COPD who agree to participate in the trial and receive the educational intervention from their GPs. The second level is GPs who are primary health care professionals and receive the educational intervention. The intervention is one session of the educational intervention with a monitor given to GPs for training in the right inhalation technique. The primary outcome is correct inhalation technique in patients. Secondary outcomes are functional status (spirometry) and quality of life. The follow-up period will be 1 year. GPs will have two visits (baseline and at the 1-year follow-up visit. Patients will have four visits (at baseline and 3, 6 and 12 months). Analysis will be done on an intention-to-treat basis.

Discussion: We carried out three previous clinical trials in patients with COPD, which showed the efficacy of an educational intervention based on monitor training to improve the inhalation technique in patients. This intervention is suitable and feasible in the context of clinical practice. Now we are seeking to know if we can improve it when the monitor is the GP (the real care provider in daily practise).

Trial registration: ISRCTN Registry identifier ISRCTN93725230 . Registered on 18 August 2014.

Keywords: COPD; Educational intervention; Inhalation techniques; Primary care professionals.

Figures

Fig. 1
Fig. 1
Study scheme. COPD chronic obstructive pulmonary disease

References

    1. Alvarez-Sala J, Cimas E, Masa JF, Miravitlles M, Molina J, Naberan K, et al. Recommendations for the care of the patient with chronic obstructive pulmonary disease [in Spanish] Arch Bronconeumol. 2001;37(7):269–78. doi: 10.1016/S0300-2896(01)75089-2.
    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD – 2014. Available from: . Accessed 8 March 2016.
    1. Miravitlles M, Sicras A, Crespo A, Cuesta M, Brosa M, Galera J, et al. Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting. Ther Adv Respir Dis. 2013;7:139–50. doi: 10.1177/1753465813484080.
    1. Donaire JG, Carrillo CT, Moral VP. Consensus on SEPAR-ALAT inhalation therapy [in Spanish] Arch Bronconeumol. 2013;49(Suppl 1):2–14.
    1. Crompton G. A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J. 2006;15:326–31. doi: 10.1016/j.pcrj.2006.09.002.
    1. Yawn B, Colice G, Hodder R. Practical aspect of inhaler use in the management of chronic obstructive pulmonary disease in primary care setting. Int J COPD. 2012;7:495–502. doi: 10.2147/COPD.S32674.
    1. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105:930–8. doi: 10.1016/j.rmed.2011.01.005.
    1. Molimard M, Rahersion C, Lignot S. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003;16:249–54. doi: 10.1089/089426803769017613.
    1. Broeders MEAC, Vincken W, Corbetta L, ADMIT Working Group The ADMIT series—issues in inhalation therapy. 7) Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique. Prim Care Respir J. 2011;20:338–43. doi: 10.4104/pcrj.2011.00062.
    1. Calışkaner AZ, Öztürk C, Ceylan E, Pekcan S, Yılmaz Ö, Öztürk S, et al. The knowledge and considerations of the physicians regarding the inhaler devices in asthma and COPD: the INTEDA-1 study. Tuberk Toraks. 2013;61:183–92. doi: 10.5578/tt.5343.
    1. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broedres M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102:593–604. doi: 10.1016/j.rmed.2007.11.003.
    1. Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med. 2006;100:1479–94. doi: 10.1016/j.rmed.2006.01.008.
    1. Barnestein Fonseca P, Leiva Fernandez J, Acero-Guasch N, Garcia Ruiz A, Prados Torres D, Leiva Fernandez F. Eficacia de una instrucción periódica. Med Fam (And) 2013;14:11–22.
    1. Leiva-Fernández J, Leiva-Fernández F, García-Ruiz A, Prados-Torres D, Barnestein-Fonseca P. Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial. BMC Pulm Med. 2014;14:70. doi: 10.1186/1471-2466-14-70.
    1. Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Arch Bronconeumol. 2012;48(7):247–57. doi: 10.1016/j.arbres.2012.04.001.
    1. León Jiménez A, Casas Maldonado F, García Gil D, Gómez González AM, Jurado Gámez B, Madueño Caro AJ, et al. Proceso asistencial integrado enfermedad pulmonar obstructiva crónica. 2. Junta de Andalucía: Consejería de Salud y Bienestar Social; 2007.
    1. National Institute for Health and Care Excellence (NICE) Chronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE guidelines [CG101] London: NICE; 2010.
    1. American Medical Directors Association (AMDA) COPD management in the long-term care setting. Columbia: American Medical Directors Association (AMDA); 2010.
    1. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:371–84.
    1. Plaza V, Sanchís J, Roura P, Molina J, Calle M, Quirce S, et al. Physicians’ knowledge of inhaler devices and inhalation techniques remains poor in Spain. J Aerosol Med Pulm Drug Deliv. 2012;25:16–22. doi: 10.1089/jamp.2011.0895.
    1. Leiva-Fernández F, Leiva-Fernández J, Zubeldia F, García-Ruiz A, Prados-Torres D, Barnestein-Fonseca P. Efficacy of two educational interventions about inhalation techniques in patients with chronic obstructive pulmonary disease (COPD). TECEPOC: study protocol for a partially randomized controlled trial (preference trial) Trials. 2012;13:64. doi: 10.1186/1745-6215-13-64.
    1. Campbell MK, Elbourne DR, Altman DG, CONSORT Group CONSORT Statement: extension to cluster randomised trials. BMJ. 2004;328:702–8. doi: 10.1136/bmj.328.7441.702.
    1. Campbell MK, Elbourne DR, Altman DG. Ensayos clínicos aleatorizados comunitarios (CONSORT CLUSTER) Med Clin (Barc) 2005;125(Suppl 1):28–31. doi: 10.1016/S0025-7753(05)72206-5.
    1. Thompson DM, Fernald DH, Mold JW. Intraclass correlation coefficients typical of cluster-randomized studies: estimates from the Robert Wood Johnson Prescription for Health projects. Ann Fam Med. 2012;10:235–40. doi: 10.1370/afm.1347.
    1. Christie J, O’Halloran P, Stevenson M. Planning a cluster randomized controlled trial: methodological issues. Nurs Res. 2009;58:128–34. doi: 10.1097/NNR.0b013e3181900cb5.
    1. Bunker JM, Reddel HK, Dennis SM, Middleton S, Schayck CP, Crockett AJ, et al. A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: study protocol. Implement Sci. 2012;7:83. doi: 10.1186/1748-5908-7-83.
    1. García-Río F, Calleb M, Burgos F, Casan P, Del Campo F, Galdiz JB, et al. Spirometry. Arch Bronconeumol. 2013;49:388–401. doi: 10.1016/j.arbres.2013.04.001.
    1. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85:751–8. doi: 10.1378/chest.85.6.751.
    1. Medical Research Council, Committee on Research into Chronic Bronchitis . Instructions for use of questionnaire on respiratory symptoms. Dawlish: W.J. Holman; 1966.
    1. Ferrer M, Alonso J, Prieto L, Plaza V, Monsó E, Marrades R, et al. Validity and reliability of the St George’s Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J. 1996;9:1160–6. doi: 10.1183/09031936.96.09061160.
    1. Lobo A, Sanz P, Marcos G, y grupo de trabajo ZARADEMP . Examen cogsnocitivo MINIMENTAL. Madrid: TEA Ed; 2002.
    1. Puffer S, Torgerson DJ, Watson J. Cluster randomized controlled trials. J Eval Clin Pract. 2005;11:479–83. doi: 10.1111/j.1365-2753.2005.00568.x.

Source: PubMed

3
Se inscrever